X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/soligenix-announces-european-patent-grant-for-use-of-dusquetide-in-oral-mucositis-301825610.html
https://www.prnewswire.com/news-releases/soligenix-announces-recent-accomplishments-and-first-quarter-2023-financial-results-301823474.html
https://www.prnewswire.com/news-releases/soligenix-announces-scheduling-of-type-a-meeting-with-the-us-fda-to-review-proposed-study-design-for-a-second-phase-3-study-evaluating-hybryte-in-the-treatment-of-cutaneous-t-cell-lymphoma-301821894.html
https://www.prnewswire.com/news-releases/soligenix-announces-closing-of-8-5-million-public-offering-301820032.html
https://www.prnewswire.com/news-releases/soligenix-announces-appointment-of-timothy-r-cote-md-to-its-board-of-directors-301814302.html
https://www.prnewswire.com/news-releases/soligenix-enters-into-exclusive-option-agreement-with-silk-road-therapeutics-for-rights-to-topical-pentoxifylline-designed-to-treat-behcets-disease-301811424.html
https://www.prnewswire.com/news-releases/soligenix-submits-type-a-meeting-request-to-us-fda-to-review-proposed-study-design-for-a-second-phase-3-study-evaluating-hybryte-in-the-treatment-of-cutaneous-t-cell-lymphoma-301804889.html
https://www.fiercebiotech.com/biotech/soligenixs-stock-takes-another-hit-fda-requests-2nd-trial-rare-cancer-candidate
https://www.prnewswire.com/news-releases/soligenix-receives-usan-approval-for-hypericin-sodium-as-nonproprietary-name-for-novel-active-ingredient-in-hybryte-and-sgx302-301790440.html
https://www.prnewswire.com/news-releases/soligenix-announces-scheduling-of-type-a-meeting-with-the-us-fda-for-hybryte-new-drug-application-in-the-treatment-of-cutaneous-t-cell-lymphoma-301786786.html
Market Place
Share 
